Investing.comQwen · 实盘不做把握 3/10不做原因:无增量信息
北京时间·🕒 发布 19:08:52·⟳ 抓取 19:10:00 +1m08s·⚡ 决策 09-02 19:17:29 +7m29s·55.1 天前
Aurora Cannabis董事会正式发布通函，一致建议股东拒绝Curaleaf的敌意收购要约
Aurora自8月19日起已公开反对Curaleaf要约（'urges shareholders to take no action'），8月24日发布防御性回应，今日董事通函仅为预期中的正式程序步骤。股价$4.05已稳定在要约隐含价$4.00附近两周，无新增事实改变要约成功/失败概率或要约价格。案例库显示我们已在此事件中连续6次判定不做。
📄 原文Investing.com↗ 原文
Aurora Cannabis urges shareholders to reject Curaleaf bid
Oil prices rise for third session as US-Iran tensions fuel supply concerns EDMONTON, AB - Aurora Cannabis Inc. (TSX:ACB…
不做 Aurora Cannabis（ACB.US）
正式拒绝是8月19日以来持续反对的预期程序步骤，非新增催化。股价$4.05已锚定在要约隐含价$4.00上方两周，无方向性edge。Curaleaf仍可继续要约，拒绝不改变法律状态。案例库显示同一事件链已6次判定不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Aurora Cannabis正式拒绝Curaleaf敌意收购是持续两周对抗中的预期程序步骤。股价$4.05已锚定在要约隐含价$4.00上方，反映市场对要约存续的定价。拒绝本身不改变要约法律状态（Curaleaf仍可继续要约），也不提供新的方向性信息。无正期望交易机会。
🔎 新鲜度:最早出现 2026-09-02 · 扩散 low · price-in 风险 high ↗
先例如何影响了这次决策
对本次决策的影响:未进行先例研究，因为事件为预期中的程序步骤且无方向性交易机会，先例不会改变AVOID结论
工具执行结果 · 成功 6 · 降级 2 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 658 ms
{"result": "search_processed_events:agent query=`acb cura hostile bid rejection | aurora cannabis directors circular unsolicited takeover | aurora cannabis reject curaleaf bid`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 70.9/72 小时、5371 条本臂决策(完整)，返回 0 条候选。未命中只表示这些 agent query 表达式没有召回候选，不能据此证明消息首发或不是重复；按当前事件继续正常研判。"} - fetch_decision_experience 成功 stock_tools HTTP · 138 ms
{ - stock_quote 成功 stock_tools HTTP · 1,028 ms
{ - stock_quote 降级 stock_tools HTTP · 473 ms
取价失败: 暂不提供美股 OTC 市场行情 CURLF - direct_instrument_candidates 成功 stock_tools HTTP · 434 ms
{ - search_case_library 成功 stock_tools HTTP · 193 ms
{"result": "search_case_library「ACB.US,CURLF.US」—— 与这些标的相关的自家决策案例(本页 7 条,该标的全历史相关记录共 10 条；ENTER 只按该标的自己的腿统计):\n◆ ACB.US：相关历史决策 6 条 · 其中该标的 ENTER 0 条(0.0%) · 我们从没在这只票上 ENTER 过\n◆ CURLF.US：相关历史决策 4 条 · 其中该标的 ENTER 0 条(0.0%) · 我们从没在这只票上 ENTER 过\n【对所查标的真 ENTER 过的:0 条 —— 相关案例里没有该标的自己的 ENTER 腿】\n【最近 7 条其它 - kb_search 成功 stock_tools HTTP · 2,218 ms
{ - stock_quote 降级 stock_tools HTTP · 296 ms
取价失败: Could not resolve 'CURA.TSX' — pass canonical CODE.MARKET (NVDA.US, 0700.HK, 600
原文全文
展开原文 · 1,969 字
Oil prices rise for third session as US-Iran tensions fuel supply concerns
EDMONTON, AB - Aurora Cannabis Inc. (TSX:ACB) (NASDAQ:ACB) filed a directors’ circular today recommending shareholders reject the unsolicited takeover bid from Curaleaf Holdings, Inc. (TSX:CURA) (OTCQX:CURLF), according to a press release statement.
Aurora’s board of directors unanimously concluded the bid is not in the best interests of the company or its shareholders following a review by a special committee of independent directors and consultation with financial and legal advisors.
Aurora holds $149 million in cash and restricted cash as of June 30, 2026, and carries no debt. Curaleaf has over $1 billion in debt and lease liabilities as of the same date, according to financial statements filed by both companies on August 5, 2026.
Under the proposed transaction, Aurora shareholders would receive Curaleaf shares in exchange for their holdings. Based on the exchange ratio, Aurora shareholders would own approximately 7.7% of the combined company but hold only approximately 3.2% of voting rights due to Curaleaf’s multi-voting share structure.
"Curaleaf is not offering you fair value for your shares, and your cash, your rights and your future upside are at stake," said Miguel Martin, executive chairman and CEO of Aurora.
The board’s financial advisor provided a written opinion dated September 1, 2026, which is included in the circular.
TD Securities Inc. stated in August 2026 that the bid undervalues Aurora and does not adequately reflect its medical cannabis leadership, balance sheet flexibility, international expertise, or long-term growth potential.
Aurora shareholders who have tendered shares can withdraw them by contacting their broker or Kingsdale Advisors. The company directed shareholders to take no action and not tender their shares to the offer.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
EDMONTON, AB - Aurora Cannabis Inc. (TSX:ACB) (NASDAQ:ACB) filed a directors’ circular today recommending shareholders reject the unsolicited takeover bid from Curaleaf Holdings, Inc. (TSX:CURA) (OTCQX:CURLF), according to a press release statement.
Aurora’s board of directors unanimously concluded the bid is not in the best interests of the company or its shareholders following a review by a special committee of independent directors and consultation with financial and legal advisors.
Aurora holds $149 million in cash and restricted cash as of June 30, 2026, and carries no debt. Curaleaf has over $1 billion in debt and lease liabilities as of the same date, according to financial statements filed by both companies on August 5, 2026.
Under the proposed transaction, Aurora shareholders would receive Curaleaf shares in exchange for their holdings. Based on the exchange ratio, Aurora shareholders would own approximately 7.7% of the combined company but hold only approximately 3.2% of voting rights due to Curaleaf’s multi-voting share structure.
"Curaleaf is not offering you fair value for your shares, and your cash, your rights and your future upside are at stake," said Miguel Martin, executive chairman and CEO of Aurora.
The board’s financial advisor provided a written opinion dated September 1, 2026, which is included in the circular.
TD Securities Inc. stated in August 2026 that the bid undervalues Aurora and does not adequately reflect its medical cannabis leadership, balance sheet flexibility, international expertise, or long-term growth potential.
Aurora shareholders who have tendered shares can withdraw them by contacting their broker or Kingsdale Advisors. The company directed shareholders to take no action and not tender their shares to the offer.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。